Venture backers sell Thiakis for £100m

Advent Ventures and Imperial Innovations have sold Thiakis to US pharmaceutical company Wyeth. The £100m price tag depends on the progress of development of Thiakis’ flagship product, a drug to tackle obesity.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this